Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study
about
Immunotherapy for metastatic renal cell carcinomaA novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse modelNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesTherapeutic cancer vaccines: past, present, and futurePD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceTargeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapyThe evolution of poxvirus vaccinesRole of vaccine therapy for renal cell carcinoma in the era of targeted therapyStructural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt-Activated Inhibitory Factor 1Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyImmunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?Immunotherapy for metastatic renal cell carcinoma.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesElimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.Novel immunotherapy in metastatic renal cell carcinoma.Immunotherapy for metastatic solid cancersEvaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer.A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.Therapeutic cancer vaccines: are we there yet?An update on TroVax for the treatment of progressive castration-resistant prostate cancerBeyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.Viral vector-based therapeutic cancer vaccinesVaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapyImmune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapyImmune microenvironments in solid tumors: new targets for therapy.Trial Watch: Therapeutic vaccines in metastatic renal cell carcinomaSelection of recombinant MVA by rescue of the essential D4R gene.The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsUpdate on prostate cancer vaccinesCD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft modelPoxviral vectors for cancer immunotherapyA vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer modelA single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.Specific immunotherapy in renal cancer: a systematic review.Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects.Tumor biology and prognostic factors in renal cell carcinoma.TroVax(®) vaccine therapy for renal cell carcinoma.
P2860
Q24186688-B350DAEC-E33E-47F5-B8A8-70A4CC8CA747Q24276422-DC250A65-7952-453A-9F6F-0DE15568E07BQ26769884-2E5E7990-EE53-4C52-8DCD-99A213ABFB13Q26852437-40D84B21-296E-4F2D-A778-F870E5CF2723Q26863283-8CA05798-F6E8-4455-B7F2-82F175C30FBDQ26865789-2C0A023C-9742-44A8-B394-7855CC01C89EQ26991589-4B901A7B-823E-49DA-BDDA-1086C7AE6E35Q26995905-A3A7F7D0-175D-45A2-9188-6605E98CD88AQ27016032-47CD143F-4B72-4642-B806-D3ED955895D1Q27681929-D40E68A7-524B-49B9-B894-B84CCAE68A4CQ28082461-96B36E95-BB71-44D3-9AEF-F23DA258D87FQ28301672-770886E6-8BC5-4D8F-9121-021FD4E1F3F8Q30234458-D2128751-E487-464E-8187-BEC7E5DC3BB0Q30358935-E5B56543-2EFB-48E6-B275-5C9DC6DA231DQ33679779-453A5018-D124-42E3-9454-6D3F6B6920C1Q33863074-813C318A-D179-45DA-9CA1-2EA3E0C5F989Q34219970-210FD6FF-74DA-49EC-BB67-C0B699C31063Q34260594-E0B3EA20-F443-48F3-A333-6754816165D0Q34464975-8F3E4E30-A271-47E7-A3C0-1A6CEEA622F4Q34786691-EADCB7F9-9A1E-4535-B79E-10FEE682997CQ35050205-142D38B8-E2A4-48F0-910E-5A4C7274D31FQ35294382-AE1F4452-5CE6-4682-B96F-0A12ACAB381FQ35515080-49271640-4D31-4B15-A52C-5103C56BB41DQ35571248-A94D1FE5-A3F0-4279-8A62-600359037B03Q35597086-A014ED1F-A768-48B8-9C52-6857703B9778Q35634179-2C246C2F-9EF8-4B81-8D0C-FAAA5D2A5B14Q35642044-9C6626CA-FE73-4E01-ABBE-41A06E81B818Q35799377-38DD559B-4238-4696-8502-879D00E09953Q35800430-CBA2324F-4881-4663-9458-A1DB49CF2CDAQ35975387-2F2F0118-AD2B-4C10-8374-96C7660586E1Q36169608-0B73C14F-A7A9-4A16-BFEC-C3FA99ECAD70Q36177214-E21D9A81-2BE8-4B40-95B6-1C32E8FF1922Q36350388-6D2AD6AA-4150-4FD5-ADDD-524B33CBD22CQ36391900-D47E0271-9E90-4FAA-AA41-3124CF7B3A4EQ36414022-E539F249-1178-4412-B7B4-3B19D147CC66Q37004283-0E4C9B3F-E596-4C3F-82A9-344C00F7D06BQ37632182-2DD6640A-9742-4C0A-BACF-BC4298AA78E8Q37725613-0224E661-EB49-4828-A712-483C79F59B72Q37846387-B1363B3F-17C6-4D07-859F-2BA5C09ADA78Q37965748-1787A5FC-346A-4B8E-B205-6B67743ACDAE
P2860
Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vaccination of metastatic rena ...... ebo-controlled phase III study
@ast
Vaccination of metastatic rena ...... ebo-controlled phase III study
@en
Vaccination of metastatic rena ...... ebo-controlled phase III study
@nl
type
label
Vaccination of metastatic rena ...... ebo-controlled phase III study
@ast
Vaccination of metastatic rena ...... ebo-controlled phase III study
@en
Vaccination of metastatic rena ...... ebo-controlled phase III study
@nl
prefLabel
Vaccination of metastatic rena ...... ebo-controlled phase III study
@ast
Vaccination of metastatic rena ...... ebo-controlled phase III study
@en
Vaccination of metastatic rena ...... ebo-controlled phase III study
@nl
P2093
P1476
Vaccination of metastatic rena ...... ebo-controlled phase III study
@en
P2093
Cezary Szczylik
Howard L Kaufman
Jackie de Belin
John A Thompson
Madusha Goonewardena
Mike McDonald
Piotr Tomczak
Richard Harrop
Robert E Hawkins
Robert J Amato
P304
P356
10.1158/1078-0432.CCR-10-2082
P407
P577
2010-11-15T00:00:00Z